First AI-designed 'universal vaccine' tested in humans: UK researchers

medicalxpress - A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a "modest" effect on immune systems in a small, early trial, according to a new study.

AI Summary: UK researchers have initiated the first human trial of a vaccine designed using artificial intelligence, aiming for broad protection beyond conventional strain-specific shots. Early-phase testing focuses on safety and immune responses, marking a novel fusion of machine learning and immunology that could speed vaccine design — if the algorithms behave.